ArticleJournal of immunotherapy and precision oncology2024

Sustained Clinical Response to Immunotherapy Followed by BET Inhibitor in a Patient with Unresectable Sinonasal NUT Carcinoma.

Harriet Herbison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.